摘要
本文从相关基因、生长因子、细胞凋亡、一氧化氮合酶及血管活性物质5个方面,对近年来血管平滑肌细胞增殖相关因素研究的新进展作一综述,进一步认识和评价经皮冠状动脉腔内成形术后再狭窄的发生机制,为再狭窄的防治提供新的思路和途径。
出处
《国外医学(老年医学分册)》
2002年第1期23-25,共3页
Foreign Medical Sciences(Geriatrics)
参考文献14
-
1Rubin P, Williams JP, Riggs PN et al. Cellular and molecular mechanisms of radiation inhibition of restenosis. Part Ⅰ: role of the macrophage and platelet-derived growth factor. Int J Radiat Oncol Biol Phys, 1998; 40(4): 929~941
-
2Uchida K, Sasahara M, Morigami N et al. Expression of platelet-derived growth fatcor B-chain in neointimal smooth muscle cells of balloon injured rabbit femoral arteries. Atherosclerosis, 1996; 124(1): 9~23
-
3Meurice T, Bauters C, Auffray JL et al. Basic fibroblast growth factor restores endothelium-dependent responses after balloon injury of rabbit arteries. Cirulation, 1996; 93(1): 18~22
-
4Bauriedel G, Hutter R, Schluckebier S et al. Decreased apoptosis as a pathogenic factor in intimal hyperplasis of human arteriosclerosis lesions. Z Kardiol, 1997; 86(8): 572~580
-
5Geng YJ, Henderson LE, Levesque EB et al. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 1997; 17(1)):2200~2208
-
6Cheng EH, Levine B, Boise LH et al. Bax-independent inhibition of apoptosis by Bcl-XL. Nature, 1996; 379(6565):554~556
-
7Zha J, Harada H, Osipov K et al. BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity. J Biol Chem, 1997; 272(39):24101~24104
-
8Pollman MJ, Hall JL, Mann MJ et al. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nat Med, 1998; 4(2): 222~227
-
9Chen L, Daum G, Forough R et al. Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in balloon-injured carotid artery. Circ Res, 1998; 82(8): 862~870
-
10Yan Z, Hansson GK. Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ Res, 1998; 82(1): 21~29
同被引文献22
-
1姚成芳,王丽,蔡生业.复方花刺参制剂对高脂模型大鼠血液流变学的改善[J].生物医学工程研究,2002,21(1):27-28. 被引量:1
-
2徐品初,林水淼,陈方敏,赵伟康,薛人华,金国琴.补肾益气方对氧化低密度脂蛋白损伤血管内皮细胞的保护作用[J].中药药理与临床,2004,20(3):25-26. 被引量:6
-
3DeNigrisF,et al. Evidence for oxidectiveactivation of e-MYC-dependent nuclear signaling in human coronary smooth muscle cell and in early lesion of wata nabe heritable hyperlipidemic rabbits:protective effects of vitamin E , circulation ,2000:24;102(17): 2111.
-
4Prati F, Imola F, Corvo P, et al. The restart project : high-dose atorvastatin helps control restenosis after stenting procedures at high risk for resteno- sis. Results from a prospective study and a matched control group com- parison[ J]. Euro Intervention, 2007,3 ( 1 ) :89-94.
-
5Qin cc, Liu ZH. In atherogenesis, the apoptosis of endothelial cell itself could directly induce over-proliferation of smooth muscle cells[ J]. Med Hypotheses, 2007, 68 (2) : 275-277.
-
6Napoli C,de Nigris F,Williams-Ignarro S,et al. Nitric oxide and athero- sclerosis:an update[ J]. Nitric Oxide,2006,15 (4) :265-279.
-
7Waidow T, Witt W, Weber E, et at. Nitric oxide donor-induced persistent inhibition of cell adhesion protein expression and NF-kappaB activation in endothelial cells ~ J ]. Nitric Oxide, 2006,15 ( 2 ) : 103 - 113.
-
8Bohm F,Pernow J. The importance of endothe lin-1 for vascular dysfunc- tion in cardiovascular disease [ J ]. Cardiovasc Res,2007,76 ( 1 ) : 8-18.
-
9Strijdom H, Chamane N, Lochner A. Nitric oxide in the cardiovascul. system:a simple molecule with complex actions [ J ]. Cardiovasc J Aft, 2009, 20 ( 5 ) :303-310.
-
10Li H, Forstermann U. Prevention of atherosclerosis by interference with the vascular nitrc oxide system[ J]. Curr Pharm Des,2009, 15 (27) : 3133-3145.
引证文献2
-
1徐品初,林水淼,金国琴,赵伟康,陈方敏.补肾益气方及其拆方对ox-LDL所致"AS"症血管平滑肌细胞病理模型的影响[J].中药药理与临床,2010,26(2):62-64. 被引量:4
-
2王华亭,魏芳,左希宏,苏国海,姚成芳,蔡生业.复方花刺参黏多糖对血管损伤后再狭窄家兔血管内膜增殖与凋亡的影响[J].疑难病杂志,2013,12(4):293-297. 被引量:3
二级引证文献7
-
1张海燕,邬伟魁,贺娅,宋伟,李芳,郑琴,杨明.中药对血管平滑肌细胞的影响[J].中国实验方剂学杂志,2011,17(21):273-278. 被引量:9
-
2迟惠英,陈川,郁志华,陈久林,申定珠,邢三丽,赵红彬.衰老因素对动脉粥样硬化大鼠血脂等指标的影响[J].中国老年学杂志,2012,32(3):550-551. 被引量:2
-
3曾霞,邓柏杨,李扬帆,何婷婷,莫小勤,黄仕任.中医复方对血管平滑肌细胞调节作用的研究进展[J].河北中医,2016,38(5):786-789. 被引量:1
-
4王强,王晓华.花刺参中三个新的三萜皂苷类化合物[J].药学实践杂志,2016,34(5):431-436. 被引量:1
-
5钟伟,王永刚,于远望,郑刚,齐婧,尚俊平.中医药防治颈动脉粥样硬化的作用机制研究进展[J].时珍国医国药,2017,28(1):190-192. 被引量:12
-
6王怀洪,严俊贤,冯永勤,方再光,王世锋,周永灿,舒培军.花刺参胚胎和幼体发育的形态观察[J].水产科学,2017,36(5):606-611. 被引量:2
-
7张静,赵外荣,施雯婷,周忠焱,陈昕琳.中医药调控平滑肌细胞增殖抑制动脉粥样硬化的研究进展[J].中华中医药杂志,2021,36(9):5429-5432. 被引量:5
-
1张小婵,程浩,黄河.60岁以上人群踝臂指数与颈动脉粥样硬化斑块相关性研究[J].中国误诊学杂志,2008,8(12):2858-2859. 被引量:1
-
2范红波,黄欣媛.NO与2型糖尿病内皮祖细胞功能异常的关系[J].中国现代医药杂志,2013,15(12):118-120. 被引量:1
-
3秦学贤.中西医结合治疗5例肠系膜血管闭塞性疾患[J].北京中医,1997,16(1):35-36.
-
4袁晋青.经皮冠状动脉腔内成形术后再狭窄的分子生物学机制[J].中国循环杂志,1996,11(9):570-573. 被引量:4
-
5胡成林.经皮冠状动脉腔内成形术后再狭窄分子生物学机制及基因治疗研究进展[J].心血管病学进展,1995,16(4):224-226. 被引量:1
-
6姚光弼.正确认识和评价拉米夫定在治疗慢性乙型肝炎中的地位[J].肝脏,2002,7(2):73-74. 被引量:28
-
7高敏.E-选择素与心血管疾病[J].医学综述,2006,12(1):60-62. 被引量:5
-
8贾朝江,刘永波,李志光,张雷,刘毅,李金萍,梅昕.经皮动脉内溶栓治疗外周动脉阻塞性病变[J].兵团医学,2008(2):24-25.
-
9余燕敏,冯继明,余红.己酮可可碱治疗糖尿病足的临床观察[J].辽宁药物与临床,2002,5(1):18-19. 被引量:6
-
10张亚兴,王志刚,许川山.声动力学疗法与血管成形术后再狭窄[J].临床超声医学杂志,2007,9(6):358-360.